Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA optimistic about PDUFA/FDA modernization package -- association's Holmer.

This article was originally published in The Tan Sheet

Executive Summary

PHRMA OPTIMISTIC ABOUT ENACTMENT OF "FDA MODERNIZATION"/PDUFA PACKAGE, Pharmaceutical Research & Manufacturers of America President Alan Holmer indicated at an April 15 briefing in Washington, D.C. Holmer noted that Senate Labor Committee ranking Democrat Edward Kennedy (Mass.), HHS Secretary Donna Shalala and the Patients' Coalition -- parties who all have opposed the linkage of FDA reform legislation to reauthorization of the Prescription Drug User Fee Act -- each expressed a recent willingness to "accept consensus or non-controversial FDA modernization items as amendments to PDUFA."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086945

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel